Related Experiment Video
Updated: May 23, 2026
10:43
Transplantation of Pancreatic Islets Into the Kidney Capsule of Diabetic Mice
Published on: October 31, 2007
Curing diabetes with transplantation?
Anja Richter1, Susan M Lerner, Bernd Schröppel
1Nephrology Division, Mount Sinai School of Medicine, New York, NY, USA.
The Mount Sinai Journal of Medicine, New York
|April 14, 2012
Summary
Type 1 diabetes impacts over a million Americans, with current insulin therapies failing to prevent serious long-term complications. Beta-cell replacement through transplantation offers a path to insulin independence and improved health outcomes.
Area of Science:
- Endocrinology
- Transplantation Medicine
- Metabolic Diseases
Background:
- Type 1 diabetes affects over 1 million people in the US, representing up to 10% of all diabetes cases.
- Current glycemic control with exogenous insulin is often incomplete, leading to severe long-term complications like retinopathy, neuropathy, vasculopathy, and nephropathy.
Purpose of the Study:
- To explore beta-cell replacement via whole-pancreas or islet transplantation as a strategy for achieving long-term insulin independence in Type 1 diabetes patients.
Main Methods:
- This study reviews the potential of whole-pancreas transplantation and islet transplantation.
- Focuses on the physiological regulation achievable through these advanced therapeutic approaches.
Main Results:
- Beta-cell replacement aims to achieve long-term insulin independence.
- Potential benefits include improved quality of life, prevention of recurrent diabetic nephropathy, stabilization of secondary complications, and enhanced survival rates.
Conclusions:
- Beta-cell replacement therapy represents a significant advancement over conventional insulin delivery methods.
- Transplantation offers a superior level of physiological regulation for Type 1 diabetes management.
Related Concept Videos
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:24Tissue Transplantation
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
01:28Kidney Transplant I: Introduction
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...